India’s basmati industry will see revenue growth moderate to 4 per cent on-year this fiscal from a phenomenal 20 per cent ...

The sector is expected to benefit from steady cash flows and low financial leverage, which will help maintain stable credit ...

Crisil Ratings reported that recent developments in Bangladesh haven't significantly impacted India's trade or the credit ...

India's basmati industry is set to see a revenue growth of around 4% this fiscal, reaching nearly Rs 70,000 crore. This ...

Strong profitability will minimise the need for debt to fund capital expenditure and to replenish inventory, thereby ...

Pharmaceutical sector set for 8-10% revenue growth in FY 25, CRISIL report: Out Bureau, New Delhi Wednesday, September 18, 2024, 15:15 Hrs [IST] The Indian pharmaceuticals sector ...

Crisil Ratings on Tuesday said the recent developments in Bangladesh did not have a significant impact on India's trade and ...

CRISIL Ratings says Bangladesh's political turmoil won't significantly affect Indian companies' credit quality, though some ...

The Indian pharmaceutical sector is expected to maintain its growth, driven by a strategy focused on increasing market share ...

CRISIL Ratings reported that recent political turmoil in Bangladesh is unlikely to affect the credit quality of Indian ...

Crisil Ratings said the effect will vary based on industry/sector-specific nuances and exposure. "We do not foresee any ...